Are you a biotech startup eager to navigate the complex landscape of first-in-human clinical trials for small molecules? This program is designed to equip you with valuable insights needed to understand and prepare your Clinical Trial Application (CTA), a critical early milestone for every biotech company. It offers an in-depth look into different aspects in the journey towards filing a CTA for small molecules, including Antisense Oligonucleotides (ASOs), siRNA and small peptides. As competition for funding is fierce, startups are expected to demonstrate a clear blueprint for their clinical trials strategy, and we want you to be ready.